Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...
Uganda launches a groundbreaking vaccine trial to combat the deadly Ebola Sudan strain A global first this rapid-response effort aims to prevent future outbreaks ...
US withdrawal from the WHO and of all foreign aid will have dire consequences for Africa. It’s time the continent took ...
Introduction While many interventions aim to raise measles vaccination coverage in low-income and middle-income countries ...
Too few leaders have learned the critical lesson that international cooperation is essential to pandemic prevention, ...
“There are vaccines that are trying to do this ... generated by a type of white blood cell called B cells. The exact mechanism of action of bNAbs has been an ongoing area of investigation. However, ...
She further explained that the report did not propose or investigate any "speculated mechanism of action" — a hypothetical explanation or theory — to suggest how the vaccine might be connected ...
Among adults in Ravensburg, Germany, financial incentives for COVID-19 vaccination did not result in significant changes to vaccine uptake and may have inadvertently lowered community vaccination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results